News from the ECOG-ACRIN Cancer Research Group
May 28, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, May 2021

Virtual Spring 2021 Group Meeting generates record attendance; screening and genomic trials return to full activity
May 28, 2021
Doctor and patient reviewing test results

Now Enrolling: EA2192/APOLLO for Pancreatic Cancer

This phase II study, led by Dr. Kim Reiss Binder, is exploring whether the addition of maintenance PARP inhibition for BRCA- or PALB2-mutated pancreatic cancer improves outcomes
May 28, 2021
Evaluation Form

ECOG-ACRIN Recognizes 22 Member Networks and Programs for Outstanding Research Performance

In an annual evaluation, 22 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
May 28, 2021
Christine Lovly, MD, PhD headshot

ECOG-ACRIN Names Vanderbilt University’s Christine Lovly as Its 2021 Young Investigator of the Year

Dr. Lovly is the recipient of the 2021 ECOG-ACRIN Young Investigator Award, a highly prestigious recognition of research excellence
May 28, 2021
Female doctor on laptop

ECOG-ACRIN and PrECOG Research at ASCO 2021

Researchers with the ECOG-ACRIN Cancer Research Group and PrECOG, LLC will present a wide range of research findings at the 2021 ASCO Annual Meeting
May 28, 2021
Doctor patient consult over laptop

Trial Spotlight: Monika Joshi on the INSPIRE Study for Bladder Cancer

The EA8185 phase II trial is the first prospective study exclusively for patients with lymph node positive bladder cancer
May 28, 2021
News in Brief

News in Brief, May 2021